EBMT-EHA CAR-T 2019 | CD123 CAR-T therapy for the treatment of AML

Elizabeth Budde

Elizabeth Budde, MD, PhD City of Hope National Medical Center, Duarte, CA, speaks at the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA) and discusses the results of a recent trial investigating CD123 CAR T-cell therapy for relapsed/refractory acute myeloid leukemia.

Share this video